INSIGHTS ON QUALITY CONTROL
-
![Pipette With Cell Culture Plate-GettyImages-520238063]( "Automation-Assisted Washing Of Multicellular 3D Spheroids")
Automation-Assisted Washing Of Multicellular 3D SpheroidsAutomated washing of 3D spheroids improves consistency, reduces cell loss, and streamlines staining workflows. See how this approach enhances reproducibility and throughput in microplate-based assays.
-
![accelerate_biologics]( "Accelerate Biologics Product Release With Seamless Viral Testing")
Accelerate Biologics Product Release With Seamless Viral TestingExplore viral safety testing for biologics, focusing on prevention, detection, and removal strategies, updated regulatory guidance, and common challenges in unprocessed bulk testing.
-
![Expanding Capabilities in QC Analyses with Advanced LC D]( "Expanding Capabilities In QC Analyses With Advanced LC Detection")
Expanding Capabilities In QC Analyses With Advanced LC DetectionToday's quality control (QC) labs need instruments that can accurately take on a wide range of tasks. Discover a system that allows QC labs to enhance their capabilities and achieve various goals.
-
![Quality Through Precision]( "Aseptic Filling Quality Through Precision")
Aseptic Filling Quality Through PrecisionPrecise measurement shapes every reliable workcell. Meet Andrew, a specialist who verifies components with micron‑level accuracy, ensuring each piece is built to perform exactly as designed.
-
Enhance Peptide Innovation With A High-Quality Supply Of Building Blocks1/29/2025
To leverage the benefits of peptide therapeutics, identify an experienced chemical material manufacturer that can produce unique peptide building blocks with quality, efficiency, and continuous compliance.
-
(Cross-) Contamination Control Through Effective Equipment Cleaning5/6/2026
Discover science-driven cleaning strategies that reduce cross-contamination, enable safe multiproduct manufacturing, and support faster, flexible GMP changeovers.
-
Aggregate Analysis Of Tirzepatide12/11/2025
A new size exclusion method effectively analyzes Tirzepatide aggregates, demonstrating robust separation and reproducibility with minimal need for organic solvents or acidic modifiers.
-
Detection And Quantification Of Amorphous Content In Materials12/30/2024
Complementary analytical techniques like DSC, MDSC, cRHp, DVS, and SolCal accurately quantify amorphous content in pharmaceuticals to ensure stability, compatibility, and efficiency.
-
Filling The Sterility Testing Gap: Traceability And 21 CFR Part 11 Compliance6/6/2024
Watch to learn about a solution that offers digital information for every stage of a sterility test while remaining compliant with 21 CFR Part 11.
QUALITY CONTROL SOLUTIONS
-
![milliporesigma mycoplasma familly]( "A Full Spectrum Of Compliant, Ready-To-Use Mycoplasma Media With An Extended Shelf Life")
As the only major supplier worldwide, we offer all three media to test for Mycoplasma according to EP 2.6.7 and USP 63 as both broth and agar plates. These ready-to-use Friis, Frey, and Hayflick culture media help to make the cumbersome compendial procedures of testing cell cultures, raw materials, intermediates, and final products for mycoplasmas easier.
-
![Esco- Streamline Closed Restricted Access Barrier System (SLC-RABS)]( "Closed-Restricted Access Barrier System For Quality Compounding")
Ensure sterile integrity with advanced barrier systems. These controls offer real-time monitoring and flexible pressure settings to protect both your products and staff effectively.
-
![TA-Instruments-DSC-2500]( "Thermal Analyzers For The Most Demanding Biopharma Applications")
Measure heat flow, weight loss, dimension change, or mechanical properties as a function of temperature.
-
![GettyImages-1600719545 lab]( "Achieving GxP Compliance With Confidence: A Practical Framework")
Understand how to confidently meet GxP compliance in the life sciences. Explore a framework encompassing people, processes, products, and services for regulatory adherence and data integrity.
-
![paylinker-cdmo-GettyImages-1287846309]( "Payload-Linker")
Learn how high‑potency infrastructure, strong impurity control, and scalable payload‑linker capabilities help teams manage risk, maintain purity, and advance toward clinical‑stage ADC development.
